Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
作者信息
Bowles Louise, Platton Sean, Yartey Nada, Dave Minal, Lee Kurtis, Hart Daniel P, MacDonald Vickie, Green Laura, Sivapalaratnam Suthesh, Pasi K John, MacCallum Peter
机构信息
Royal London Hospital, London, United Kingdom
出版信息
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
Abstract
摘要
相似文献
1
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.新冠病毒肺炎患者的狼疮抗凝物与异常凝血检测
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
2
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病（COVID-19）患者狼疮抗凝物阳性的评估
JAMA Netw Open. 2020 Aug 3;3(8):e2017539. doi: 10.1001/jamanetworkopen.2020.17539.
3
Coagulation abnormalities and thrombosis in patients with COVID-19.新型冠状病毒肺炎患者的凝血异常与血栓形成
Lancet Haematol. 2020 Jun;7(6):e438-e440. doi: 10.1016/S2352-3026(20)30145-9. Epub 2020 May 11.
4
Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.一名狼疮抗凝物阳性的新冠病毒肺炎女性患者发生急性缺血性卒中
J Clin Rheumatol. 2020 Sep;26(6):236-237. doi: 10.1097/RHU.0000000000001565.
5
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection.SARS-CoV-2 感染患者凝血功能的显著变化。
Clin Chem Lab Med. 2020 Jun 25;58(7):1116-1120. doi: 10.1515/cclm-2020-0188.
6
The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.接受治疗性抗凝治疗的危重症 COVID-19 患者的止血情况：一项观察性研究。
Medicine (Baltimore). 2020 Nov 20;99(47):e23365. doi: 10.1097/MD.0000000000023365.
7
COVID-19 coagulopathy: an evolving story.新冠病毒感染相关凝血功能障碍：一个不断演变的故事。
Lancet Haematol. 2020 Jun;7(6):e425. doi: 10.1016/S2352-3026(20)30151-4.
8
Bilateral Acute Cardioembolic Limb Ischemia After Coronavirus Disease 2019 Pneumonia in a Lung Transplant Recipient: A Case Report.一名肺移植受者在2019冠状病毒病肺炎后出现双侧急性心源性肢体缺血：病例报告
Transplant Proc. 2020 Nov;52(9):2715-2718. doi: 10.1016/j.transproceed.2020.06.024. Epub 2020 Jun 30.
9
The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.抗凝治疗对新冠病毒感染患者死亡率的影响。
Am J Cardiol. 2020 Nov 1;134:155-157. doi: 10.1016/j.amjcard.2020.08.005. Epub 2020 Aug 15.
10
Hemostasis profile in COVID-19 infection.新型冠状病毒肺炎感染中的止血情况
Rev Assoc Med Bras (1992). 2020 May;66(5):571-572. doi: 10.1590/1806-9282.66.5.571. Epub 2020 Jul 3.
引用本文的文献
1
SARS-CoV-2 Coronavirus Disease in Patients with Underlying Congenital Inferior Vena Cava Anomalies.患有先天性下腔静脉异常的患者中的新型冠状病毒肺炎
Biomedicines. 2025 May 29;13(6):1336. doi: 10.3390/biomedicines13061336.
2
COVID-19 coagulopathy and antiphospholipid syndrome.新型冠状病毒肺炎凝血病与抗磷脂综合征
Rev Colomb Reumatol. 2022 Jun;29:S25-S34. doi: 10.1016/j.rcreu.2021.02.013. Epub 2021 Aug 27.
3
Anticoagulation in venovenous extracorporeal membrane oxygenation.静脉-静脉体外膜肺氧合中的抗凝
Front Med (Lausanne). 2025 Mar 4;12:1530411. doi: 10.3389/fmed.2025.1530411. eCollection 2025.
4
Inhibiting NINJ1-dependent plasma membrane rupture protects against inflammasome-induced blood coagulation and inflammation.抑制NINJ1依赖性质膜破裂可预防炎性小体诱导的血液凝固和炎症。
Elife. 2025 Mar 17;12:RP91329. doi: 10.7554/eLife.91329.
5
Dynamics of coagulation proteins upon ICU admission and after one year of recovery from COVID-19: a preliminary study.COVID-19患者入住重症监护病房时及康复一年后凝血蛋白的动态变化：一项初步研究。
Front Cell Infect Microbiol. 2025 Jan 8;14:1489936. doi: 10.3389/fcimb.2024.1489936. eCollection 2024.
6
Autoantibodies in COVID-19: implications for disease severity and clinical outcomes.新冠病毒病中的自身抗体：对疾病严重程度和临床结局的影响
Front Immunol. 2025 Jan 6;15:1509289. doi: 10.3389/fimmu.2024.1509289. eCollection 2024.
7
Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19.针对重症 COVID-19 中刺突蛋白受体结合域的促血栓形成抗体。
Blood. 2025 Feb 6;145(6):635-647. doi: 10.1182/blood.2024025010.
8
Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination.针对 COVID-19 疫苗接种后发生罕见凝血功能障碍的患者，可检测蛋白 S 自身抗体。
Sci Rep. 2024 Oct 18;14(1):24512. doi: 10.1038/s41598-024-75514-x.
9
The Mediating Role of Inflammation and Coagulation in the Association Between COVID-19 and 3-Month Outcome After Stroke During the Omicron Wave.炎症和凝血在奥密克戎毒株流行期间新冠病毒感染与中风后3个月预后关联中的中介作用
J Inflamm Res. 2024 Oct 10;17:7171-7182. doi: 10.2147/JIR.S465127. eCollection 2024.
10
COVID-19 Coagulopathy.新型冠状病毒肺炎凝血病
Life (Basel). 2024 Jul 29;14(8):953. doi: 10.3390/life14080953.
本文引用的文献
1
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.严重严重急性呼吸综合征冠状病毒 2 型感染患者的血栓形成风险高：一项多中心前瞻性队列研究。
Intensive Care Med. 2020 Jun;46(6):1089-1098. doi: 10.1007/s00134-020-06062-x. Epub 2020 May 4.
2
High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients.抗凝治疗的重症 COVID-19 患者中静脉血栓栓塞事件发生率高。
J Thromb Haemost. 2020 Jul;18(7):1743-1746. doi: 10.1111/jth.14869. Epub 2020 May 27.
3
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
4
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
Zotero 插件